Sunesis Pharmaceutic (SNSS) Stock Analyst Ratings

NASDAQ:SNSS

5.32
+1.04 (+24.3%)
At close: Feb 24, 2021
4.8
-0.52 (-9.77%)
After Hours: 2/24/2021, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

73

ChartMill assigns a Buy % Consensus number of 73% to SNSS. The Buy consensus is the weighted average rating of the current analysts ratings.

  • SNSS was analyzed by 3 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about SNSS.
  • In the last month the buy percentage rose by 13 points. So the trust of analysts is improving.
  • Only 3 analysts analyzed SNSS. So this is just the average opinion of a couple of analysts.

Related screens

Find peers with buy consensus above 85%
SNSS Historical Analyst RatingsSNSS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 0 0 0 0 0
SNSS Current Analyst RatingSNSS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5
Up and Down Grades

Sunesis Pharmaceutic / SNSS FAQ

How do analysts rate Sunesis Pharmaceutic (SNSS)?

The consensus rating for Sunesis Pharmaceutic (SNSS) is 73.4 / 100 . This indicates that analysts generally have a positive outlook on the stock.